Alleye

📍 Zürich, Switzerland👥 4 employees💰 Last funded Jun 2017
Alleye aims to prevent blindness so that people enjoy longer and healthier lives. Alleye was launched in 2015 and is a subsidiary of medignition. Alleye helps people to detect retinal diseases or to monitor the course of an existing retinal disease. The Alleye test is specialized in early detection and monitoring of age-related macular degeneration (AMD) and diabetic macular edema (DME). With the Alleye app, users can regularly test their visual performance on a mobile device. As an Alleye provider, eye doctors, opticians, and pharmacists can manage their customers and their Alleye data via alleye.io.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Alleye?
Alleye has 1 investors on record on gritt.io.
When did Alleye last raise funding?
The most recent investment in Alleye recorded on gritt.io was in June 2017.
What industry is Alleye in?
Alleye operates in IT Services and IT Consulting. Find similar IT Services and IT Consulting investors on gritt.io.
Where is Alleye based?
Alleye is headquartered in Zürich, Switzerland.